A novel macrophage-based dimerising chimeric antigen receptor technology for solid tumour ablation

  • Strangward, Patrick (Principal Investigator)
  • Sieger, Dirk (Co-investigator)

Project Details

StatusActive
Effective start/end date20/11/23 → 31/12/24

Funding

  • Cancer Research Technology Ltd: £19,762.32